NanoRepro Cash Flow | StatInvestor

Health Care & Life Sciences » Medical Equipment & Supplies | NanoRepro AG

NanoRepro AG | Cash Flow

Fiscal year is January-December. All values EUR Thousands.

2013

2015

2016

2017

2018

Net Income before Extraordinaries

498.00

1,176.00

551.70

734.10

289.60

Depreciation, Depletion & Amortization

38.00

217.00

208.80

193.00

339

Other Funds

630.00

400.00

82.10

Funds from Operations

1,004.00

1,134.00

900.50

541.10

32.70

Changes in Working Capital

221.00

42.00

125.90

614.00

232.10

Net Operating Cash Flow

783.00

1,092.00

774.60

1,155.10

264.80

Capital Expenditures

7.00

232.00

381.00

3.80

Purchase/Sale of Investments

346.50

Net Investing Cash Flow

7.00

232.00

380.40

350.30

Issuance/Reduction of Debt, Net

108.00

142.50

Net Financing Cash Flow

1,282.00

1,435.00

1,454.60

1,503.30

Net Change in Cash

475.00

111.00

299.60

2.10

Free Cash Flow

790.00

1,324.00

775.40

1,158.90

Other Sources

0.60

Change in Capital Stock

652.00

1,143.00

1,312.10

1,523.40

Exchange Rate Effect

17.00

About NanoRepro

View Profile

Address	Untergasse 8 Marburg Hessen 35037 Germany
Employees	-
Website	http://www.nano.ag
Updated	07/08/2019
NanoRepro AG engages in the development, manufacture, and distribution of diagnostic tests and food supplements for home and professional use. It distributes its products under the AllergoCHECK, MilkCHECK, EggCHECK, FertiQUICK, OvuQUICK, GraviQUICK, VagiQUICK, MenoQUICK, GlutenCHECK, Heli-C-CHECK, FerritinCHECK, FOBCHECK, Alkohol Test, and DrugTEST brands. The company was founded by Olaf Stiller in 2006 and is headquartered in Marburg, Germany.